Ferring has R&D centres in 12 countries
Ferring has R&D centres in Brazil, China, Denmark, India, Israel, Japan, Russia, Switzerland, the UK and two in the US.
The main pharmaceutical development hub is in Copenhagen. The Copenhagen and Parsippany sites drive and execute product innovation and development of new molecular entities as well as further development of our existing in-line products to better meet patient needs or address new disease areas.
Ferring has manufacturing sites in 13 countries
In-house production is carried out in Argentina, China, the Czech Republic, Denmark, Germany, India, Israel, Mexico, Switzerland, the UK and the US.
We invest in necessary facilities and equipment to produce the medicines we discover and make a difference to people’s health and quality of life.
Learn more about our history